Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 1
2005 5
2006 8
2007 8
2008 2
2009 9
2010 9
2011 13
2012 15
2013 19
2014 14
2015 16
2016 28
2017 28
2018 42
2019 44
2020 64
2021 89
2022 114
2023 122
2024 43

Text availability

Article attribute

Article type

Publication date

Search Results

623 results

Results by year

Filters applied: . Clear all
Page 1
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.
Modi S, Jacot W, Yamashita T, Sohn J, Vidal M, Tokunaga E, Tsurutani J, Ueno NT, Prat A, Chae YS, Lee KS, Niikura N, Park YH, Xu B, Wang X, Gil-Gil M, Li W, Pierga JY, Im SA, Moore HCF, Rugo HS, Yerushalmi R, Zagouri F, Gombos A, Kim SB, Liu Q, Luo T, Saura C, Schmid P, Sun T, Gambhire D, Yung L, Wang Y, Singh J, Vitazka P, Meinhardt G, Harbeck N, Cameron DA; DESTINY-Breast04 Trial Investigators. Modi S, et al. Among authors: luo t. N Engl J Med. 2022 Jul 7;387(1):9-20. doi: 10.1056/NEJMoa2203690. Epub 2022 Jun 5. N Engl J Med. 2022. PMID: 35665782 Free PMC article. Clinical Trial.
Targeting mTOR for cancer therapy.
Hua H, Kong Q, Zhang H, Wang J, Luo T, Jiang Y. Hua H, et al. Among authors: luo t. J Hematol Oncol. 2019 Jul 5;12(1):71. doi: 10.1186/s13045-019-0754-1. J Hematol Oncol. 2019. PMID: 31277692 Free PMC article. Review.
PI3K/AKT/mTOR-Targeted Therapy for Breast Cancer.
Zhu K, Wu Y, He P, Fan Y, Zhong X, Zheng H, Luo T. Zhu K, et al. Among authors: luo t. Cells. 2022 Aug 12;11(16):2508. doi: 10.3390/cells11162508. Cells. 2022. PMID: 36010585 Free PMC article. Review.
Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial.
Ma F, Yan M, Li W, Ouyang Q, Tong Z, Teng Y, Wang Y, Wang S, Geng C, Luo T, Zhong J, Zhang Q, Liu Q, Zeng X, Sun T, Mo Q, Liu H, Cheng Y, Cheng J, Wang X, Nie J, Yang J, Wu X, Wang X, Li H, Ye C, Dong F, Wu S, Zhu X, Xu B; PHILA Investigators. Ma F, et al. Among authors: luo t. BMJ. 2023 Oct 31;383:e076065. doi: 10.1136/bmj-2023-076065. BMJ. 2023. PMID: 37907210 Free PMC article. Clinical Trial.
Candidalysin is a fungal peptide toxin critical for mucosal infection.
Moyes DL, Wilson D, Richardson JP, Mogavero S, Tang SX, Wernecke J, Höfs S, Gratacap RL, Robbins J, Runglall M, Murciano C, Blagojevic M, Thavaraj S, Förster TM, Hebecker B, Kasper L, Vizcay G, Iancu SI, Kichik N, Häder A, Kurzai O, Luo T, Krüger T, Kniemeyer O, Cota E, Bader O, Wheeler RT, Gutsmann T, Hube B, Naglik JR. Moyes DL, et al. Among authors: luo t. Nature. 2016 Apr 7;532(7597):64-8. doi: 10.1038/nature17625. Epub 2016 Mar 30. Nature. 2016. PMID: 27027296 Free PMC article.
Myxoid adrenocortical adenoma.
Lai B, He Z, Luo T, Huang Y. Lai B, et al. Among authors: luo t. Asian J Surg. 2023 Apr;46(4):1813-1814. doi: 10.1016/j.asjsur.2022.10.043. Epub 2022 Oct 27. Asian J Surg. 2023. PMID: 36891757 Free article. No abstract available.
623 results